Occudo Quantitative Strategies LP Collegium Pharmaceutical, Inc Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$21.06 - $24.0 $402,182 - $458,328
-19,097 Reduced 44.08%
24,228 $520,000
Q1 2023

May 15, 2023
BUY
$23.0 - $29.88 $722,913 - $939,158
31,431 Added 264.26%
43,325 $1.04 Million
Q4 2022

Feb 14, 2023
SELL
$16.14 - $23.55 $212,531 - $310,106
-13,168 Reduced 52.54%
11,894 $275,000
Q3 2022

Nov 14, 2022
BUY
$15.46 - $20.1 $387,458 - $503,746
25,062 New
25,062 $401,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email